1. Academic Validation
  2. Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses

  • Antiviral Res. 2020 Jun;178:104805. doi: 10.1016/j.antiviral.2020.104805.
Mike Bray Craig Rayner François Noël David Jans Kylie Wagstaff
Figures
Products